Clinical Trial Update: Safety and Tolerance of RAG-17 in Amyotrophic Lateral Sclerosis Patients With SOD1 Gene Mutation [EARLY_Phase 1]

View source ↗

Summary

Early-phase results describe the safety and tolerability of RAG-17 in amyotrophic lateral sclerosis patients with SOD1 gene mutation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• RAG-17

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Gene Mutation | EARLY_Phase 1 | Status: COMPLETED